Table of Contents Author Guidelines Submit a Manuscript
Experimental Diabetes Research
Volume 2012, Article ID 616313, 9 pages
http://dx.doi.org/10.1155/2012/616313
Review Article

New Experimental Models of Diabetic Nephropathy in Mice Models of Type 2 Diabetes: Efforts to Replicate Human Nephropathy

1Department of Nephrology, Hospital del Mar-IMIM, 08010 Barcelona, Spain
2Division of Nephrology and Hypertension, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA

Received 8 July 2011; Accepted 15 November 2011

Academic Editor: Yasuhiko Tomino

Copyright © 2012 María José Soler et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. “Incidence of end-stage renal disease among persons with diabetes—United States, 1990–2002,” Morbidity and Mortality Weekly Report, vol. 54, pp. 1097–1100, 2005.
  2. J. H. Stewart, M. R. E. McCredie, and S. P. McDonald, “The incidence of treated end-stage renal disease in New Zealand Maori and Pacific Island people and in Indigenous Australians,” Nephrology Dialysis Transplantation, vol. 19, no. 3, pp. 678–685, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. P. C. W. Van Dijk, K. J. Jager, F. De Charro et al., “Renal replacement therapy in Europe: the results of a collaborative effort by the ERA-EDTA registry and six national or regional registries,” Nephrology Dialysis Transplantation, vol. 16, no. 6, pp. 1120–1129, 2001. View at Google Scholar · View at Scopus
  4. G. Soldatos and M. E. Cooper, “Diabetic nephropathy: important pathophysiologic mechanisms,” Diabetes Research and Clinical Practice, vol. 82, no. 1, pp. S75–S79, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. M. D. Breyer, E. Böttinger, F. C. Brosius et al., “Mouse models of diabetic nephropathy,” Journal of the American Society of Nephrology, vol. 16, no. 1, pp. 27–45, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. T. W. C. Tervaert, A. L. Mooyaart, K. Amann et al., “Pathologic classification of diabetic nephropathy,” Journal of the American Society of Nephrology, vol. 21, no. 4, pp. 556–563, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. F. C. Brosius, C. E. Alpers, E. P. Bottinger et al., “Mouse models of diabetic nephropathy,” Journal of the American Society of Nephrology, vol. 20, no. 12, pp. 2503–2512, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. K. M. I. Caron, L. R. James, G. Lee, H. S. Kim, and O. Smithies, “Lifelong genetic minipumps,” Physiological Genomics, vol. 20, pp. 203–209, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. K. J. Williams, G. Qiu, H. K. Usui et al., “Decorin deficiency enhances progressive nephropathy in diabetic mice,” American Journal of Pathology, vol. 171, no. 5, pp. 1441–1450, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. D. D. Gellman, C. L. Pirani, J. F. Soothill et al., “Diabetic nephropathy: a clinical and pathologic study based on renal biopsies,” Medicine, vol. 38, pp. 321–367, 1959. View at Google Scholar · View at Scopus
  11. C. S. Chang, A. H. Yang, and C. H. Chang, “Nodular glomerulosclerosis mimicking diabetic nephropathy without overt diabetes mellitus,” Clinical Nephrology, vol. 64, no. 4, pp. 300–304, 2005. View at Google Scholar · View at Scopus
  12. G. S. Markowitz, J. Lin, A. M. Valeri, C. Avila, S. H. Nasr, and V. D. D'Agati, “Idiopathic nodular glomerulosclerosis is a distinct clinicopathologic entity linked to hypertension and smoking,” Human Pathology, vol. 33, no. 8, pp. 826–835, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. S. D. Navaneethan, S. Singh, and W. Choudhry, “Nodular glomerulosclerosis in a non-diabetic patient: case report and review of literature,” Journal of Nephrology, vol. 18, no. 5, pp. 613–615, 2005. View at Google Scholar · View at Scopus
  14. L. C. Stout, S. Kumar, and E. B. Whorton, “Insudative lesions—their pathogenesis and association with glomerular obsolescence in diabetes: a dynamic hypothesis based on single views of advancing human diabetic nephropathy,” Human Pathology, vol. 25, no. 11, pp. 1213–1227, 1994. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Bohle, M. Wehrmann, O. Bogenschutz, C. Batz, C. A. Muller, and G. A. Muller, “The pathogenesis of chronic renal failure in diabetic nephropathy. Investigation of 488 cases of diabetic glomerulosclerosis,” Pathology Research and Practice, vol. 187, no. 2-3, pp. 251–259, 1991. View at Google Scholar · View at Scopus
  16. K. P. Hummel, M. M. Dickie, and D. L. Coleman, “Diabetes, a new mutation in the mouse,” Science, vol. 153, no. 3740, pp. 1127–1128, 1966. View at Google Scholar · View at Scopus
  17. A. M. Ingalls, M. M. Dickie, and G. D. Snell, “Obese, a new mutation in the house mouse,” The Journal of Heredity, vol. 41, no. 12, pp. 317–318, 1950. View at Google Scholar · View at Scopus
  18. G. H. Lee, R. Proenca, J. M. Montez et al., “Abnormal splicing of the leptin receptor in diabetic mice,” Nature, vol. 379, no. 6566, pp. 632–635, 1996. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Ye, J. Wysocki, J. William, M. J. Soler, I. Cokic, and D. Batlle, “Glomerular localization and expression of angiotensin-converting enzyme 2 and angiotensin-converting enzyme: implications for albuminuria in diabetes,” Journal of the American Society of Nephrology, vol. 17, no. 11, pp. 3067–3075, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. M. P. Cohen, K. Sharma, Y. Jin et al., “Prevention of diabetic nephropathy in db/db mice with glycated albumin antagonists. A novel treatment strategy,” Journal of Clinical Investigation, vol. 95, no. 5, pp. 2338–2345, 1995. View at Google Scholar · View at Scopus
  21. S. W. Hong, M. Isono, S. Chen, M. C. Iglesias-De La Cruz, D. C. Han, and F. N. Ziyadeh, “Increased glomerular and tubular expression of transforming growth factor-β1, its type II receptor, and activation of the smad signaling pathway in the db/db mouse,” American Journal of Pathology, vol. 158, no. 5, pp. 1653–1663, 2001. View at Google Scholar · View at Scopus
  22. F. N. Ziyadeh, B. B. Hoffman, D. C. Han et al., “Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-β antibody in db/db diabetic mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 14, pp. 8015–8020, 2000. View at Publisher · View at Google Scholar · View at Scopus
  23. M. P. Cohen, S. Chen, F. N. Ziyadeh et al., “Evidence linking glycated albumin to altered glomerular nephrin and VEGF expression, proteinuria, and diabetic nephropathy,” Kidney International, vol. 68, no. 4, pp. 1554–1561, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. K. Sharma, P. McCue, and S. R. Dunn, “Diabetic kidney disease in the db/db mouse,” American Journal of Physiology, vol. 284, no. 6, pp. F1138–F1144, 2003. View at Google Scholar · View at Scopus
  25. H. J. Zhao, S. Wang, H. Cheng et al., “Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice,” Journal of the American Society of Nephrology, vol. 17, no. 10, pp. 2664–2669, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. S. C. Chua, W. K. Chung, X. S. Wu-Peng et al., “Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor,” Science, vol. 271, no. 5251, pp. 994–996, 1996. View at Google Scholar · View at Scopus
  27. S. Chua, S. Mei Liu, Q. Li, L. Yang, V. Thassanapaff, and P. Fisher, “Differential beta cell responses to hyperglycaemia and insulin resistance in two novel congenic strains of diabetes (FVB-Leprdb) and obese (DBA-Lepob) mice,” Diabetologia, vol. 45, no. 7, pp. 976–990, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. F. Bielschowsky and M. Bielschowsky, “The New Zealand strain of obese mice; their response to stilboestrol and to insulin,” Australian Journal of Experimental Biology and Medical Science, vol. 34, pp. 181–198, 1956. View at Google Scholar
  29. E. H. Leiter and P. C. Reifsnyder, “Differential Levels of Diabetogenic Stress in Two New Mouse Models of Obesity and Type 2 Diabetes,” Diabetes, vol. 53, no. 1, pp. S4–S11, 2004. View at Google Scholar · View at Scopus
  30. P. C. Reifsnyder and E. H. Leiter, “Deconstructing and reconstructing obesity-induced diabetes (diabesity) in mice,” Diabetes, vol. 51, no. 3, pp. 825–832, 2002. View at Google Scholar · View at Scopus
  31. K. A. Melez, W. A. Boegel, and A. D. Steinberg, “Therapeutic studies in New Zealand mice: VII. Successful androgen treatment of NZB/NZW F1 females of different ages,” Arthritis and Rheumatism, vol. 23, no. 1, pp. 41–47, 1980. View at Google Scholar · View at Scopus
  32. K. A. Melez, L. C. Harrison, J. N. Gilliam, and A. D. Steinberg, “Diabetes is associated with autoimmunity in the New Zealand Obese (NZO) mouse,” Diabetes, vol. 29, no. 10, pp. 835–840, 1980. View at Google Scholar · View at Scopus
  33. E. J. Michaud, R. L. Mynatt, R. J. Miltenberger et al., “Role of the agouti gene in obesity,” Journal of Endocrinology, vol. 155, no. 2, pp. 207–209, 1997. View at Publisher · View at Google Scholar · View at Scopus
  34. R. J. Miltenberger, R. L. Mynatt, J. E. Wilkinson, and R. P. Woychik, “The role of the agouti gene in the yellow obese syndrome,” Journal of Nutrition, vol. 127, no. 9, 1997. View at Google Scholar · View at Scopus
  35. T. Ito, M. Tanimoto, K. Yamada et al., “Glomerular changes in the KK-Ay/Ta mouse: a possible model for human type 2 diabetic nephropathy,” Nephrology, vol. 11, no. 1, pp. 29–35, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. H. Ninomiya, T. Inomata, and K. Ogihara, “Microvasculature of Hydronephrotic Kidneys in KK-A y Mice,” Journal of Veterinary Medical Science, vol. 62, no. 10, pp. 1093–1098, 2000. View at Google Scholar · View at Scopus
  37. R. S. Surwit, M. N. Feinglos, J. Rodin et al., “Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and A/J mice,” Metabolism, vol. 44, no. 5, pp. 645–651, 1995. View at Google Scholar · View at Scopus
  38. S. A. Schreyer, D. L. Wilson, and R. C. Leboeuf, “C57BL/6 mice fed high fat diets as models for diabetes-accelerated atherosclerosis,” Atherosclerosis, vol. 136, no. 1, pp. 17–24, 1998. View at Publisher · View at Google Scholar · View at Scopus
  39. D. A. Towler, M. Bidder, T. Latifi, T. Coleman, and C. F. Semenkovich, “Diet-induced diabetes activates an osteogenic gene regulatory program in the aortas of low density lipoprotein receptor-deficient mice,” Journal of Biological Chemistry, vol. 273, no. 46, pp. 30427–30434, 1998. View at Publisher · View at Google Scholar · View at Scopus
  40. N. Deji, S. Kume, S. I. Araki et al., “Structural and functional changes in the kidneys of high-fat diet-induced obese mice,” American Journal of Physiology, vol. 296, no. 1, pp. F118–F126, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Mohan, R. L. Reddick, N. Musi et al., “Diabetic eNOS knockout mice develop distinct macro- and microvascular complications,” Laboratory Investigation, vol. 88, no. 5, pp. 515–528, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. T. J. Allen, M. E. Cooper, and H. Y. Lan, “Use of genetic mouse models in the study of diabetic nephropathy,” Current Atherosclerosis Reports, vol. 6, no. 3, pp. 197–202, 2004. View at Google Scholar · View at Scopus
  43. S. M. Clee and A. D. Attie, “The genetic landscape of type 2 diabetes in mice,” Endocrine Reviews, vol. 28, no. 1, pp. 48–83, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. S. M. Clee, S. T. Nadler, and A. D. Attie, “Genetic and genomic studies of the BTBR ob/ob mouse model of type 2 diabetes,” American Journal of Therapeutics, vol. 12, no. 6, pp. 491–498, 2005. View at Publisher · View at Google Scholar · View at Scopus
  45. T. Ranheim, C. Dumke, K. L. Schueler, G. D. Cartee, and A. D. Attie, “Interaction between BTBR and C57BL/6J genomes produces an insulin resistance syndrome in (BTBR x C57BL/6J) F1 mice,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 17, no. 11, pp. 3286–3293, 1997. View at Google Scholar · View at Scopus
  46. K. L. Hudkins, W. Pichaiwong, T. Wietecha et al., “BTBR Ob/Ob mutant mice model progressive diabetic nephropathy,” Journal of the American Society of Nephrology, vol. 21, no. 9, pp. 1533–1542, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. M. A. Nauck, B. Baller, and J. J. Meier, “Gastric inhibitory polypeptide and glucagon-like peptide-1 in the pathogenesis of type 2 diabetes,” Diabetes, vol. 53, no. 3, pp. S190–S196, 2004. View at Publisher · View at Google Scholar · View at Scopus
  48. H. Sakuraba, H. Mizukami, N. Yagihashi, R. Wada, C. Hanyu, and S. Yagihashi, “Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese Type II diabetic patients,” Diabetologia, vol. 45, no. 1, pp. 85–96, 2002. View at Publisher · View at Google Scholar · View at Scopus
  49. N. Herbach, I. Scharier, A. Blutke et al., “Diabetic kidney lesions of GIPRdn transgenic mice: podocyte hypertrophy and thickening of the GBM precede glomerular hypertrophy and glomerulosclerosis,” American Journal of Physiology—Renal Physiology, vol. 296, no. 4, pp. F819–F829, 2009. View at Publisher · View at Google Scholar
  50. Y. Wang, K. Heilig, T. Saunders et al., “Transgenic overexpression of GLUT1 in mouse glomeruli produces renal disease resembling diabetic glomerulosclerosis,” American Journal of Physiology, vol. 299, no. 1, pp. F99–F111, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. V. Eremina, M. Sood, J. Haigh et al., “Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases,” Journal of Clinical Investigation, vol. 111, no. 5, pp. 707–716, 2003. View at Publisher · View at Google Scholar · View at Scopus
  52. G. I. Welsh, L. J. Hale, V. Eremina et al., “Insulin signaling to the glomerular podocyte is critical for normal kidney function,” Cell Metabolism, vol. 12, no. 4, pp. 329–340, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. S. B. Gurley, S. E. Clare, K. P. Snow, A. Hu, T. W. Meyer, and T. M. Coffman, “Impact of genetic background on nephropathy in diabetic mice,” American Journal of Physiology, vol. 290, no. 1, pp. F214–F222, 2006. View at Publisher · View at Google Scholar · View at Scopus